LS

Laura Stoppel

Board of Directors at Indapta Therapeutics

Somerville, Massachusetts

Overview

Work Experience

RC

RA Capital Management, L.P.

  • Principal

    2020 - Current

  • Analyst

    2020 - 2020

  • Senior Associate

    2018 - 2020

  • Associate

    2016 - 2018

AB

Artiva Biotherapeutics

  • Board of Directors

    2020

NT

Nimbus Therapeutics

  • Board of Directors

    2020

AP

Acumen Pharmaceuticals, Inc.

  • Board of Directors

    2020

Indapta Therapeutics

  • Board of Directors

    2022

VB

Vor Biopharma

  • Board Observer

    2019 - 2021

Education

Investments

CellCentric

Series Unknown

Total Funding: $35M

Gameto

Series B

Total Funding: $73M

Nimbus Therapeutics

Series Unknown

Total Funding: $640M

Indapta Therapeutics

Series A

Total Funding: $50M

Relevant Websites